Skip to Content

9 3 5214 (Hydrochlorothiazide and Moexipril 12.5 mg / 15 mg)

Pill imprint 9 3 5214 has been identified as Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg 9 3 5214 Front
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg 9 3 5214 Back
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg 9 3 5214
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg 9 3 5214
Hydrochlorothiazide and moexipril hydrochloride
Imprint:
9 3 5214
Strength:
12.5 mg / 15 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
ACE inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-5214

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide